SCHEMBL6565833

SCHEMBL6565833

COC(=O)c1cc(NC(=O)Nc2ccccc2)ccc1OCc1cc(C)ccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
RAB9A P51151 3/20 0.53
LMNA P02545 3/20 0.53
NPC1 O15118 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MAPT P10636 6/20 0.50
ALDH1A1 P00352 2/20 0.50
HIF1A Q16665 2/20 0.48
ALOX5 P09917 1/20 0.46
EPHX2 P34913 1/20 0.46
ESRRA P11474 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HSP90AA1 P07900 1/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
LRRK2 Q5S007 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567857 0.92 MEN1 (0.53) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6564697 0.90 MEN1 (0.56) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6566726 0.86 MEN1 (0.56) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6564693 0.84 LRRK2 (0.57) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL6564360 0.84 MEN1 (0.54) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6566692 0.83 MEN1 (0.61) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6566712 0.83 MEN1 (0.65) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6565955 0.83 KMT2A (0.55) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6566664 0.80 MEN1 (0.57) MEN1KMT2ARAB9ALMNANPC1
SCHEMBL6567662 0.80 MEN1 (0.52) MEN1KMT2ALMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885RAB9A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.